Skip to main content
TipRanks
Go Ultimate75% OFF

Immucell (ICCC) Q3 2022 Earnings Report

81 Followers

ICCC Q3 2022 EPS Results

Actual EPS
-$0.09
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$0.02

ICCC Q3 2022 Revenue Results

Actual Revenue
$4.80M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-6.88%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/21/2022
Time
After Close
Conference Call
Monday, November 21, 2022

Q3 2022 Earnings Call Audio

ICCC Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

ICCC Earnings History

ICCC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 12, 20262026 (Q3)―--0.01―
Aug 13, 20262026 (Q2)―0.200.06257.14% (+0.14)
May 14, 20262026 (Q1)―0.210.1633.54% (+0.05)
Mar 04, 20262025 (Q4)―-0.320.06-643.10% (-0.37)
Nov 13, 20252025 (Q3)―-0.01-0.0982.56% (+0.07)
Aug 14, 20252025 (Q2)―0.06-0.2128.57% (+0.25)
May 14, 20252025 (Q1)―0.16-0.06387.50% (+0.22)
Feb 25, 20252024 (Q4)―0.06-0.15139.46% (+0.20)
Nov 13, 20242024 (Q3)―-0.09-0.1228.93% (+0.04)
Aug 13, 20242024 (Q2)―-0.20-0.18-10.11% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed